Alto Neuroscience Management
Management criteria checks 0/4
Alto Neuroscience's CEO is Amit Etkin, appointed in Mar 2019, has a tenure of 5.83 years. total yearly compensation is $1.86M, comprised of 21.1% salary and 78.9% bonuses, including company stock and options. directly owns 4.47% of the company’s shares, worth $5.56M. The average tenure of the management team and the board of directors is 2 years and 2.8 years respectively.
Key information
Amit Etkin
Chief executive officer
US$1.9m
Total compensation
| CEO salary percentage | 21.1% |
| CEO tenure | 5.8yrs |
| CEO ownership | 4.5% |
| Management average tenure | 2yrs |
| Board average tenure | 2.8yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$57m |
| Jun 30 2024 | n/a | n/a | -US$50m |
| Mar 31 2024 | n/a | n/a | -US$42m |
| Dec 31 2023 | US$2m | US$393k | -US$36m |
Compensation vs Market: Amit's total compensation ($USD1.86M) is above average for companies of similar size in the US market ($USD645.47K).
Compensation vs Earnings: Insufficient data to compare Amit's compensation with company performance.
CEO
Amit Etkin (47 yo)
5.8yrs
Tenure
US$1,863,297
Compensation
Dr. Amit Etkin, MD, PhD., is the Founder of Alto Neuroscience, Inc. and has been its Chairman of the Board and Chief Executive Officer since March 2019, President since November 2023 and serves as its Dire...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 5.8yrs | US$1.86m | 4.47% $ 5.6m | |
| CFO & Secretary | 2.2yrs | US$1.77m | 0.029% $ 35.6k | |
| Chief Medical Officer | 3.5yrs | US$1.35m | 0.15% $ 183.7k | |
| Chief Operating Officer | less than a year | no data | no data | |
| Vice President of Finance & Accounting | 2yrs | no data | no data | |
| General Counsel & Chief Administrative Officer | 1.9yrs | no data | no data | |
| Chief Development Officer | 1.3yrs | no data | no data | |
| Senior Vice President of Innovation | 1.3yrs | no data | no data |
2.0yrs
Average Tenure
48yo
Average Age
Experienced Management: ANRO's management team is not considered experienced ( 2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 5.8yrs | US$1.86m | 4.47% $ 5.6m | |
| Independent Director | 3.3yrs | US$53.68k | 0.089% $ 110.3k | |
| Scientific Advisor | no data | no data | no data | |
| Independent Director | 1.3yrs | US$107.37k | 0% $ 0 | |
| Scientific Advisor | no data | no data | no data | |
| Non-Employee Independent Director | less than a year | no data | 0% $ 0 | |
| Non-Employee Independent Director | 2.8yrs | no data | 0.18% $ 219.9k | |
| Scientific Advisor | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Lead Independent Director | 2.8yrs | no data | 0% $ 0 | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data |
2.8yrs
Average Tenure
59.5yo
Average Age
Experienced Board: ANRO's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 11:20 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alto Neuroscience, Inc. is covered by 7 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Brian Skorney | Baird |
| Lin Tsai | Jefferies LLC |
| Justin Walsh | JonesTrading Institutional Services, LLC |